Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market: Overview
Sample preparation is one of the most crucial steps in analysis of any particular biological substance or chemical. Analytical procedure usually consists of steps such as sampling, sample preservation, sample preparation, separation detection, and data analysis. After sampling and sample preservation, the next vital step is usually the sample preparation, which consumes over 70% of the analysis time.
Since sample preparation is the most time consuming step in any analysis and end-user industry constantly insists on more efficient products and automation systems to achieve high throughput. The results of analysis directly affect the decision-making process and therefore, the market for sample preparation in genomics, proteomics, and epigenomics continues to remain dynamic through regular introduction of more efficient products. In almost all cases, sample preparation is an imperative step in analysis because many samples are not ready for direct introduction into the analytical instrument. The ever increasing regulatory requirements for testing substances, chemicals, and pharmaceuticals promise a better outlook for the global sample preparation in genomics, proteomics, and epigenomics market.
Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market: Trends and Opportunities
Increase in research and development expenditure in life science is the primary driver in the global market for sample preparation. The life science sector comprises pharmaceutical, biotech, and healthcare segments. This is progressively achieving profitable revenues globally. This has been partly attributed to emerging markets and positive demographics in those markets as well as due to global leading edge research resulting in blockbuster innovations. These innovations are facilitated by meticulous and vigorous R&D efforts by global players and academia in all the aforementioned segments. R&D requires high throughput sampling and analysis. Hence, it is driving the sample preparation market.
Advancements in technology pertaining to sample preparation products is another favorable factor in the global market for sample preparation in genomics, proteomics, and epigenomics. The past years have seen substantial advancements in technologies for enhancing sample preparation processes. These include automation and superior technique-based advancements such as solid supported liquid-liquid extraction as a development to traditional technique of liquid-liquid extraction. For instance, Agilent’s 7696A Sample Prep WorkBench provides consistent and precise results by eliminating errors associated with routine sample preparation procedures, such as dilution and derivatization.
Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market: Region-wise Outlook
Geographically, the global sample preparation market can be segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2015, North America held a 39.5% share in the global market, and is expected to retain strong foothold during the forecast period of 2016–2024 due to the high adoption of superior technologies across all end-user segments. Moreover, factors such as investments in cutting edge genomics, proteomics, and epigenetics research, rising emphasis on remedies for environmental concerns, and concentration of some of the world’s major pharmaceutical and biotechnology organizations and academic institutes in the region will propel the sample preparation market in this region.
Europe held the second most prominent share of 28.2% in 2015, owing to factors such as focus on cutting edge genomics and proteomics studies, leading innovative drug development clusters, and the eclectic mix of skilled scientist in academics and research. A total of 25 European biotech IPOs were recorded in 2015, raising around US$1.22 bn. Asia Pacific is considered the most lucrative market and is anticipated to grow at the strongest rate during the forecast period. This growth is attributed to strong economic growth, increase in disposable income, rise in healthcare infrastructure, and the growing investments by market players in the region. Moreover, the pharmaceutical industry in Asia Pacific is rapidly expanding, which will lay the platform for investment on sample preparation products. For instance, in June 2016, Pfizer, Inc. announced investment of US$350 mn to build a biotech center in China by 2018. Moreover, Asia Pacific has two of the world’s most populous countries, China and India. Hence, the number of underserved end-user pool is also high in the region, offering significant opportunities in the market.
Some of the key players in the global market for sample preparation in genomics, proteomics, and epigenomics include Agilent Technologies, Bio-Rad Laboratories, Biotage AB, Danaher Corporation, F Hoffman La Roche, Illumina, Inc., Merck KgaA, PerkinElmer, Inc., Qiagen N.V., Thermo Fisher Scientific, Inc., and Waters Corporation.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.